CHICAGO, June 5, 2018 /PRNewswire/ -- Label Insight, the market leader for transparency, today introduced the American Heart Association Heart-Check Standard Certification Industry View, which ...

Bayer’s Kerendia, already FDA approved in one cardiometabolic indication, now has data from a pivotal test that support expanding the drug’s label to heart failure. In preliminary results reported ...

Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy® (semaglutide 2.4 mg) is the first obesity ...

Lumping Asian American, Native Hawaiian and Pacific Islander pregnant people into one health category ...

(RTTNews) - Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of the Wegovy (semaglutide 2 ...

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly ...

After Abiomed’s attempts to expand the user pool for its Impella RP heart pump were less than successful, the FDA has updated the wording of the device’s label to direct it toward only the patients ...

Credit: FDA. These products were distributed nationwide. Marlex Pharmaceuticals is recalling 1 lot of Digoxin Tablets 0.125mg and 1 lot of Digoxin Tablets 0.25mg due to a label mix-up. According to ...